TITLE

Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy

AUTHOR(S)
Barraclough, R. M.; Gillies, A. J.
PUB. DATE
August 2001
SOURCE
Thorax;Aug2001, Vol. 56 Issue 8, p664
SOURCE TYPE
Academic Journal
DOC. TYPE
Report
ABSTRACT
Pulmonary alveolar proteinosis is a rare condition traditionally requiring treatment with whole lung lavage. The case is presented of a young man who obtained complete remission following treatment with granulocyte-macrophage colony stimulating factor, a new treatment option.
ACCESSION #
12915281

 

Related Articles

  • A case of pulmonary alveolar proteinosis treated with whole lung lavage. Bansal, Avdhesh; Sikri, Vikas // Indian Journal of Critical Care Medicine;Sep/Oct2013, Vol. 17 Issue 5, p314 

    Pulmonary alveolar proteinosis represents a rare syndrome characterized by the accumulation of proteinaceous phospholipid-laden material in the alveoli. This leads to impaired gas exchange and arterial hypoxemia of varying degrees. The diagnosis is confirmed by lung biopsy. Sequential whole-lung...

  • Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Latzin, P.; Tredano, M.; Wüst, Y.; de Blic, J.; Nicolai, T.; Bewig, B.; Stanzel, F.; Köhler, D.; Bohuau, M.; Griese, M. // Thorax;Jan2005, Vol. 60 Issue 1, p39 

    Background: Auto-antibodies against granulocyte-macrophage colony stimulating factor (GM-CSF) may be central to the pathogenesis of adult sporadic pulmonary alveolar proteinosis (PAP). The role of anti- GM-CSF auto-antibodies in paediatric farms of PAP is as yet unclear. Methods: Anti-GM-CSF...

  • GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis. Uchida, Kanji; Beck, David C.; Yamamoto, Takashi; Berclaz, Pierre-Yves; Abe, Shuichi; Staudt, Margaret K.; Carey, Brenna C.; Filippi, Marie-Dominique; Wert, Susan E.; Denson, Lee A.; Puchalski, Jonathan T.; Hauck, Diane M.; Trapnell, Bruce C. // New England Journal of Medicine;2/8/2007, Vol. 356 Issue 6, p567 

    Background: Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte–macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in...

  • Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis. Lin, F.-C.; Chang, G.-D.; Chern, M.-S.; Chen, Y.-C.; Chang, S.-C. // Thorax;Jun2006, Vol. 61 Issue 6, p528 

    Background: The role of anti-granulocyte-macrophage colony stimulating factor (GM-CSF) antibodies as a diagnostic marker in idiopathic pulmonary alveolar proteinosis (iPAP) remains unclear. Methods: Anti-GM-CSF antibodies were detected in blood and bronchoalveolar lavage fluid (BAL) fluid in 13...

  • Long-term follow-up and treatment of congenital alveolar proteinosis.  // BMC Pediatrics;2011, Vol. 11 Issue 1, p72 

    The article presents a case study focusing on long-term follow-up and treatment of congenital alveolar proteinosis in a 2.5 year old girl. The case demonstrated that the long term management from early childhood into young adolescence of severe alveolar proteinosis due to...

  • Relationship Between Diffuse Pulmonary Fibrosis, Alveolar Proteinosis, and Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies. Luisetti, Maurizio; Bruno, Pierdonato; Kadija, Zamir; Suzuki, Takuji; Raffa, Salvatore; Torrisi, Maria Rosaria; Campo, Ilaria; Mariani, Francesca; Pozzi, Ernesto; Trapnell, Bruce C.; Mariotta, Salvatore // Respiratory Care;Oct2011, Vol. 56 Issue 10, p1608 

    Extensive pulmonary fibrosis is a rare occurrence in pulmonary alveolar proteinosis. We report 2 cases that have interesting implications. A female patient was diagnosed with autoimmune pulmonary alveolar proteinosis that evolved over 7 years into diffuse fibrosis. In a male patient with diffuse...

  • Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis. Liou, Theodore G.; Adler, Frederick R.; Keogh, Ruth H.; Yanping Li; Jensen, Judy L.; Walsh, William; Packer, Kristyn; Clark, Teresa; Carveth, Holly; Chen, Jun; Rogers, Shaunessy L.; Lane, Christen; Moore, James; Sturrock, Anne; Paine III, Robert; Cox, David R.; Hoidal, John R.; Kreindler, James L. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Lung function, acute pulmonary exacerbations (APE), and weight are the best clinical predictors of survival in cystic fibrosis (CF); however, underlying mechanisms are incompletely understood. Biomarkers of current disease state predictive of future outcomes might identify mechanisms and...

  • Segmental Lung Lavage with Fiberoptic Bronchoscopy in a Patient with Special Presentation of Pulmonary Alveolar Proteinosis. Sadeghi, Hasan Allah // Tanaffos;2013, Vol. 12 Issue 4, p48 

    Pulmonary alveolar proteinosis (PAP) is rare. It is characterized by the accumulation of proteinaceous materials in the alveoli. Typical appearance of BAL fluid (BALF) and positive PAS staining of BALF in conjunction with typical clinical and radiographic manifestations may be diagnostic of PAP....

  • Preventive Effect of Hochu-ekki-to on Lipopolysaccharide-Induced Acute Lung Injury in BALB/c Mice. Tajima, Shunji; Bando, Masashi; Yamasawa, Hideaki; Ohno, Shoji; Moriyama, Hiroshi; Takada, Toshinori; Suzuki, Eiichi; Gejyo, Fumitake; Sugiyama, Yukihiko // Lung;Nov/Dec2006, Vol. 184 Issue 6, p318 

    This study was designed to investigate the effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the development of lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. ALI was induced in female BALB/c mice by the intranasal administration of 0.1 mg/kg LPS. The mice were...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics